Article
Clinically reported heterozygous mutations in the PINK1 kinase domain exert a gene dosage effect.
Human mutation - 1 Nov 2009
Tan Eng-King, Refai F Shaffra, Siddique Mobin, Yap Karen, Ho Patrick, Fook-Chong Stephanie, Zhao Yi
Abstract excerpt
Mutations in the gene encoding phosphatase and tensin homolog (PTEN)-induced kinase 1 (PINK1) have been associated with the loss of dopaminergic neurons characteristic of familial and sporadic Parkinson disease. We developed an in vitro system of stable human dopaminergic neuronal cell lines coexpressing an equivalent copy of normal and mutant PINK1 to simulate "heterozygous" and "homozygous" states in patients....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
